After 30 days of NLCD, CHC patients showed a significant reduction in Th17 cells frequency, and an increase in the percentage of Treg cells, thus improving Treg/Th17 balance. The decrease in Th17 cells correlated with a decline in IL-17 and IL-22 serum levels. The gene discussed is IL17A; the disease is cryohydrocytosis.